Cargando…
[(18)F]-AV-1451 binding in the substantia nigra as a marker of neuromelanin in Lewy body diseases
While [(18)F]-AV-1451 was developed as a PET radiotracer with high affinity for hyperphosphorylated tau, it has been proposed that loss of ‘off-target’ [(18)F]-AV-1451 binding to neuromelanin in the substantia nigra could be a surrogate marker of Lewy body diseases. [(18)F]-AV-1451 binding was measu...
Autores principales: | Mak, Elijah, Kouli, Antonina, Holland, Negin, Nicastro, Nicolas, Savulich, George, Surendranathan, Ajenthan, Malpetti, Maura, Manavaki, Roido, Hong, Young T, Fryer, Tim D, Aigbirhio, Franklin, Rowe, James B, O’Brien, John T, Williams-Gray, Caroline H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8410984/ https://www.ncbi.nlm.nih.gov/pubmed/34485906 http://dx.doi.org/10.1093/braincomms/fcab177 |
Ejemplares similares
-
Imaging tau burden in dementia with Lewy bodies using [(18)F]-AV1451 positron emission tomography
por: Mak, Elijah, et al.
Publicado: (2021) -
Molecular pathology and synaptic loss in primary tauopathies: an (18)F-AV-1451 and (11)C-UCB-J PET study
por: Holland, Negin, et al.
Publicado: (2021) -
(18)F-AV-1451 positron emission tomography in Alzheimer’s disease and progressive supranuclear palsy
por: Passamonti, Luca, et al.
Publicado: (2017) -
(18)F-AV1451 PET imaging and multimodal MRI changes in progressive supranuclear palsy
por: Nicastro, Nicolas, et al.
Publicado: (2019) -
Corrigendum to: Spatiotemporal changes in substantia nigra neuromelanin content in Parkinson’s disease
Publicado: (2020)